Prompted by the results from bulk tumor tissues, and given the potential limitations of bulk expression in fully representing cellular diversity (47), we sought to explore if this upregulation of inhibitory checkpoints and protumoral molecules similarly manifests at the intracellular level in immune effector cells, specifically NK, CD4+, and CD8+ cells. Here, CD8A is linked to neoplasm.